GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Phase 2

Completed

Conditions: Purpura, Thrombocytopaenic, Idiopathic

Interventions: Drug: eltrombopag

First Posted Date: 2007-01-18

Last Posted Date: 2013-07-30

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 66

Registration Number: NCT00424177

Locations: 🇷🇺
GSK Investigational Site, Moscow, Russian Federation

An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.

Phase 1

Completed

Conditions: Healthy Subjects

First Posted Date: 2007-01-18

Last Posted Date: 2009-05-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 25

Registration Number: NCT00423761

Locations: 🇺🇸
GSK Investigational Site, Dallas, Texas, United States

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2007-01-17

Last Posted Date: 2016-10-28

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 60

Registration Number: NCT00422604

Locations: 🇬🇧
GSK Investigational Site, Manchester, United Kingdom

Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.

Phase 3

Completed

Conditions: Neuropathy, Diabetic

Interventions: Drug: rosiglitazone

First Posted Date: 2007-01-17

Last Posted Date: 2016-09-15

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 36

Registration Number: NCT00422955

Locations: 🇳🇱
GSK Investigational Site, Nijmegen, Netherlands

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

Phase 1

Completed

Conditions: Restless Legs Syndrome

First Posted Date: 2007-01-17

Last Posted Date: 2016-10-26

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 48

Registration Number: NCT00422994

Locations: 🇬🇧
GSK Investigational Site, London, United Kingdom

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Phase 2

Completed

Conditions: Neoplasms, Breast

Interventions: Drug: letrozole
Drug: lapatinib
Other: placebo

First Posted Date: 2007-01-17

Last Posted Date: 2016-05-12

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 92

Registration Number: NCT00422903

Locations: 🇪🇸
GSK Investigational Site, Badalona, Spain

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Phase 3

Completed

Conditions: Infections, Papillomavirus
Papillomavirus Vaccines

Interventions: Biological: GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)
Biological: Gardasil ® (Merck & Co. Inc)
Biological: Placebo

First Posted Date: 2007-01-17

Last Posted Date: 2020-01-02

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1106

Registration Number: NCT00423046

Locations: 🇺🇸
GSK Investigational Site, Wenatchee, Washington, United States

A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.

Phase 4

Terminated

Conditions: Analgesia
Sedation

First Posted Date: 2007-01-12

Last Posted Date: 2018-04-03

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 164

Registration Number: NCT00421720

Locations: 🇩🇪
GSK Clinical Trials Call Center, Tubingen, Germany

Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome

Phase 2

Completed

Conditions: Irritable Bowel Syndrome (IBS)

Interventions: Drug: GW876008
Other: Placebo

First Posted Date: 2007-01-12

Last Posted Date: 2018-01-31

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 133

Registration Number: NCT00421707

Locations: 🇨🇦
GSK Investigational Site, Saskatoon, Saskatchewan, Canada

Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

Phase 4

Terminated

Conditions: Benign Prostatic Hyperplasia

First Posted Date: 2007-01-12

Last Posted Date: 2007-11-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 276

Registration Number: NCT00421421

Locations: 🇬🇧
GSK Clinical Trials Call Centre, Derby, United Kingdom
🇬🇧
GSK Clinical Trials Call Center, Wakefield, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy